The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE120100131
Funder
Australian Research Council
Funding Amount
$150,000.00
Summary
Biomaterials characterisation facility. The convergence of nanotechnology and biotechnology offers new opportunities to prepare nanoengineered materials for applications in biomedicine. The Biomaterials Characterisation Facility will provide equipment to characterise such nanoengineered materials to underpin advances in therapeutic drug delivery and tissue engineering.
Multimodal polymeric nanocarriers designed for the controlled and site specific delivery of nitric oxide. Nitric oxide (NO) plays a key role in the development of different diseases. The chronic deficiency of NO results in severe problems such as cardiovascular diseases, liver fibrosis, diabetes, cancer, Alzheimer’s diseases, etc. This project will describe a new method to deliver specifically nitric oxide using macromolecules.
A nanoengineered solution to drug delivery in bone. This project presents an exciting new approach of applying nanotechnology to bone research. By combining our expertise in nanoengineering of new materials, mathematical modelling and bone biology, this project will result in a well-characterised model for drug delivery into bone and lead to a new therapeutic approach for treating bone diseases.
The development of yoctowells on magnetic nanoparticles as both tiny chemical reactors and biological models. This project seeks to develop an innovative and cutting-edge research program in biomimicry by studying a surface functionalised system - the so called yoctowells - on magnetic nanoparticles, by studying their inclusion behaviour and utilising the intrinsic magnetic properties for isolation and manipulation in catalysis, medicine and electronics.
Advancing Nanomedicine Through Particle Technology
Funder
National Health and Medical Research Council
Funding Amount
$876,005.00
Summary
This proposal will support the development of advanced particle systems to improve the delivery of medicines in neurological diseases, HIV, diabetes and cancer. It will provide important insights for particle-based therapeutic delivery that are expected to underpin progress on nanotechnology in the areas of biology and medicine. These developments in nanotechnology-enabled medicines towards commercialisation will ultimately improve the health and quality of life of Australians.
Atomized mucoadhesive particles for pulmonary gene delivery. Scientific and technological advances in material science, biotechnology and biomedical devices are poised to revolutionise healthcare and medicine. By using precisely engineered biomaterials in an efficient miniature electronic inhalation device, a mist of inhalable therapeutics can be generated to deliver improved lung healthcare for Australians.
Discovery Early Career Researcher Award - Grant ID: DE130100488
Funder
Australian Research Council
Funding Amount
$375,000.00
Summary
Cellular dynamics of nanoengineered particles. Nanotechnology has the capacity to drive a new wave of biological innovation through engineering materials at the nanoscale. This project will advance understanding of how nanoengineered materials interact with biological systems to enable the development of nanomaterials for future translational research.
Multifunctional biodegradable nanoparticles for enhanced DNA vaccine delivery. DNA vaccine, which shows better immunological and economic merits than conventional vaccines, suffers clinical failure due to the difficulty of delivering intact DNA molecules to relevant cells. This project seeks to develop smart polymer nanospheres to protect the DNA molecules from premature degradation in order to improve its efficacy.
The Use Of Gene-Silencing Nanodrugs To Inhibit Lung Cancer Growth
Funder
National Health and Medical Research Council
Funding Amount
$452,950.00
Summary
Lung cancer accounts for the most cancer deaths worldwide. This research proposal will use state-of-the-art nanomedicines designed to penetrate lung tumours and suppress a gene which drives cancer growth and resistance to chemotherapy drugs. Our results could underpin new approaches that revolutionise more effective and less toxic treatments for a highly lethal malignancy.
Development of dense gas technology platforms for the formulation of oral vaccines. This project will aim to develop a technology platform that enables the formulation of vaccines that can be delivered orally and this research has the potential to radically change existing vaccination regimens. The availability of needle-free vaccination also has potential for considerable societal and economic impact in developing countries.